Skip to content

Community based prevention and control for Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population

Community based prevention and control for Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in the isolated population

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029601
Enrollment
Unknown
Registered
2020-02-06
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Sponsors

Hubei Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Suspected and confirmed cases of pneumonia in accordance with the above new signs of coronavirus infection and the standard of clinical common diagnosis; 2. Aged 18-65 years old; 3. Signing the general informed consent form.

Exclusion criteria

Exclusion criteria: 1. Clear evidences?of bacterial infection; 2. Serious primary diseases judged by researchers,such as heart, kidney, lung, endocrine, blood, metabolism and gastrointestinal tract,?may affect the patients' participation in the trial or the outcome of the study; 3. Family history of mental illness or mental illness; 4. Allergic constitution or multi drug allergy; 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
the negative conversion ratio;the proportion of general patients with advanced severe disease;confirmed rate of suspected cases;

Secondary

MeasureTime frame
Traditional Chinese medical syndrome scale;Body temperature;

Countries

China

Contacts

Public ContactTong Xiaolin

Hubei Provincial Hospital of TCM

252417083@qq.com+86 18908628577

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026